Position
Fidelity in Madrigal Pharmaceuticals, Inc.
Back to the book · All holders of MDGL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.8M$523.47 → $536.95
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 439.4K | $255.9M | — | — | — | 0.0% |
| Q1 2026 | 511.7K | $267.9M | $523.47 | −$25.9M | $37.9M | 0.0% |
| Q2 2026 | 356.2K | $191.3M | $536.95 | $4.8M | −$81.4M | 0.0% |